£425K
EHE Ventures led the round with support from Deepbridge Capital and Lyva Labs to accelerate product development and regulatory approval.
Spotlight Pathology develops artificial intelligence tools to speed up blood cancer diagnosis.
Spotlight Pathology is a medical technology company developing artificial intelligence tools to assist clinicians in diagnosing blood cancers. Its platform uses proprietary computer vision models to streamline lymph node and bone marrow biopsy workflows.
Martin Fergie
Co-founder

EHE Ventures led the round with support from Deepbridge Capital and Lyva Labs to accelerate product development and regulatory approval.
The pre-seed investment from LYVA Labs will accelerate product development and commercialisation.